Novocure Limited
A maker of cancer treatments that harness electricity rather than drugs, Novocure produces the Optune device, a wearable system that delivers low-intensity electric fields (called Tumor Treating Fields) to slow tumor growth in adults with glioblastoma, an aggressive brain cancer. It was founded in 2000 by Yoram Palti, a biophysicist who first tested his theory in a lab he set up in the basement of his home in Israel.
Granted 168.6K · Sold 47.1K
Granted 23.8K
Granted 63.1K · Sold 9.7K
Granted 67.9K
Granted 33.1K · Sold 2.9K
Granted 40.1K · Sold 1.1K
Granted 400.3K · Sold 71.9K
Granted 55.1K · Sold 6.4K
Sold 1.1K
Granted 11.6K · Sold 2.9K
Granted 45.1K · Sold 49.0K
Granted 11.6K · Sold 2.9K
Granted 11.6K
Granted 11.6K · Sold 2.9K
Granted 11.6K · Sold 2.9K
Granted 11.6K · Sold 2.9K
Granted 11.6K · Sold 2.9K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Leonard Frank XChief Executive Officer · 5 transactions | +35.9% | 459.5K | 168.6K | — | 47.1K |
| Cordova AshleyFormer Chief Executive Officer · 4 transactions | -0.8% | 422.6K | 23.8K | — | — |
| Weinberg UriChf Medical and Innovation Ofr · 4 transactions | +25% | 267.2K | 63.1K | — | 9.7K |
| Ben Arye BarakGeneral Counsel · 2 transactions | +38.9% | 242.5K | 67.9K | — | — |
| Vernon W AnthonyDirector · 3 transactions | +16.8% | 209.3K | 33.1K | — | 2.9K |
| Puri Michal NathChief Human Resources Officer · 2 transactions | +24% | 201.3K | 40.1K | — | 1.1K |
| Doyle William FExecutive Chairman, Director · 4 transactions | -63.7% | 200.0K | 400.3K | — | 71.9K |
| Brackmann ChristophChief Financial Officer · 2 transactions | +36.3% | 182.8K | 55.1K | — | 6.4K |
| Leupin NicolasFormer Chief Medical Officer · 1 transaction | -1.1% | 103.0K | — | — | 1.1K |
| Leung GabrielDirector · 2 transactions | +9.4% | 101.1K | 11.6K | — | 2.9K |
| Paravasthu MukundChief Operating Officer · 4 transactions | -5.1% | 72.8K | 45.1K | — | 49.0K |
| Hung DavidDirector · 2 transactions | +37% | 32.1K | 11.6K | — | 2.9K |
| Madden Martin J.Director · 1 transaction | +62.2% | 30.3K | 11.6K | — | — |
| Scannell Timothy JDirector · 2 transactions | +50.3% | 25.9K | 11.6K | — | 2.9K |
| Hilleman Jeryl LDirector · 2 transactions | +51.6% | 25.5K | 11.6K | — | 2.9K |
| Ocean Allyson JDirector · 2 transactions | +60.7% | 22.9K | 11.6K | — | 2.9K |
| Stafford KristinDirector · 2 transactions | +60.7% | 22.9K | 11.6K | — | 2.9K |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 6 months: -206.9K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.